FDA cleared advantage Natural Cycles is the only app FDA cleared as a birth control, signaling a strong regulatory credibility edge and an opportunity to position expanded clinical and data collaboration with healthcare providers and clinics seeking trusted digital contraceptive solutions.

Financing momentum With total funding around $102M and recent $99.5M financing rounds, there is evident investor confidence and potential for strategic partnerships, co-marketing, or channel partnerships to accelerate adoption in new markets and product extensions.

Product expansion Lifecycle expansion through NC° Perimenopause and NC° Postpartum offerings, plus a wristband thermometer replacement, creates cross-sell opportunities to expand customer lifetime value by targeting broader fertility, menopause, and postpartum support markets.

Tech and data edge An in-house Medical, Algorithm, and Data Team combined with cloud-native tech (Kubernetes, React) enables scalable digital health solutions and potential for enterprise integrations, API partnerships, and data-driven collaborations with clinics and healthcare platforms.

Growth signals Recent executive hires and Nordic AB expansion signal organizational growth and go-to-market scaling potential, presenting openings for strategic partnerships with regional healthcare providers, insurers, and digital health distributors to accelerate market penetration.